Sökresultat - "HanliKang®"

Long-term outcomes with HLX01 (HanliKang^®), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 study

Qin, Yan, Song, Yongping, Wang, Dong, Bai, Ou, Feng, Jifeng, Sun, Xiuhua, Qiu, Lihua, Yang, Jianmin, Yang, Yu, Wang, Zhao, Hu, Jianda, Wang, Huaqing, Su, Hang, Jin, Zhengming, Qian, Wenbin, Jin, Chuan, Zhang, Mingzhi, Yu, Ding, Liu, Li, Chen, Guoan, Li, Yarong, Sun, Tao, Jin, Jie, Bao, Huizheng, Du, Xin, Zhou, Hui, Fu, Gan, Shi, Yuankai^{Aff1, IDs12885024118769_cor28}